Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what could be next for this Alzheimer's drug developer.
Digital Pathology Market. In 2023, the digital pathology market is expected to be valued at USD 7,035.8 million USD. By 2033, the market is anticipated to reach USD 24,961.8 milli ...
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical-stage, specialty pharmaceutical company focused on developing and commercializing novel treatments for rare and orphan ...